Literature DB >> 7615521

A small GTP-binding protein, Rho, associates with the platelet-derived growth factor type-beta receptor upon ligand binding.

M Zubiaur1, J Sancho, C Terhorst, D V Faller.   

Abstract

Ligand binding to the platelet-derived growth factor (PDGF) receptor initiates a complex and diverging cascade of signaling pathways. GTP-binding proteins with intrinsic GTPase activity (G-proteins) frequently link cell surface receptors to intracellular signaling pathways, but no close associations of the PDGF receptor and any small G-proteins, nor any such associations activated by ligand binding to the receptor have been previously reported. We demonstrate that a small GTP-binding protein binds specifically to the murine and human PDGF type-beta receptor. In response to PDGF-BB stimulation, there is an increase in the amount of labeled small G-protein associated with the PDGF type-beta receptor. The GTP-binding protein did not undergo ligand-induced association with a mutant receptor protein that was unable to bind ATP. Proteolytic cleavage analysis, together with two-dimensional separation techniques, identified the small G-protein specifically associating with the PDGF type-beta receptor after ligand binding as a member of the Rho family. This was confirmed by demonstration that the small G-protein coimmunoprecipitated by the anti-PDGF receptor antibody was a substrate for the ADP-ribosyltransferase C3 exoenzyme. Thus, the PDGF type-beta receptor may form a complex with one or more small G-proteins upon binding PDGF-BB, and the Rho small G-protein is likely to be an important component of the proteins making up the multimeric signaling complex of the PDGF type-beta receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615521     DOI: 10.1074/jbc.270.29.17221

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities.

Authors:  F M Donovan; C J Pike; C W Cotman; D D Cunningham
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

2.  Ca2+ channel activation by platelet-derived growth factor-induced tyrosine phosphorylation and Ras guanine triphosphate-binding proteins in rat glomerular mesangial cells.

Authors:  H Ma; H Matsunaga; B Li; B Schieffer; M B Marrero; B N Ling
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

3.  The IL-1 receptor and Rho directly associate to drive cell activation in inflammation.

Authors:  R Singh; B Wang; A Shirvaikar; S Khan; S Kamat; J R Schelling; M Konieczkowski; J R Sedor
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

4.  Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.

Authors:  D Gingras; S Lamy; R Béliveau
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

5.  TGFbeta3 signaling activates transcription of the LEF1 gene to induce epithelial mesenchymal transformation during mouse palate development.

Authors:  Ali Nawshad; Elizabeth D Hay
Journal:  J Cell Biol       Date:  2003-12-22       Impact factor: 10.539

6.  A critical role for PDGFRα signaling in medial nasal process development.

Authors:  Fenglei He; Philippe Soriano
Journal:  PLoS Genet       Date:  2013-09-26       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.